About The Medical Condition Drug Evaluation, FDA Phase 4
Find the definition of the medical term Drug Evaluation, FDA Phase 4. Drug Evaluation, FDA Phase 4 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 4
| Drug Evaluation, FDA Phase 4 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 4?
Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Computer-Assisted Drug Therapy ‐ Adjunctive computer programs in providing drug treatment to…
- Tc-99m-Diethyl IDA ‐ A nontoxic radiopharmaceutical that is used in the clinical evaluation…
- Oncogene Protein src ‐ A tyrosine-specific protein kinase encoded by the v-src oncogene…
- Drugs, Investigational New ‐ Drugs which have received FDA approval for human testing but…
- Bepridil Monohydrochloride ‐ A long-acting calcium-blocking agent with significant anti-anginal…
- Insufficiencies, Kidney ‐ The inability of a kidney to excrete metabolites at normal plasma…
- Polyester, Pentosane Sulfuric ‐ A sulfated pentosyl polysaccharide with heparin-like…
- Chondroitinsulfatases ‐ A group of enzymes that catalyze the hydrolysis of various sulfate…
- Assassin Bug ‐ A family of winged insects of the suborder HETEROPTERA, called…
- Mesozoas ‐ Animals that have no…